Tools for causality assessment in drug-induced liver disease

Purpose of review There are three liver-specific causality assessment tools currently available to guide clinical diagnosis of Drug-Induced Liver Injury (DILI): Roussel-Uclaf Causality Assessment Method (RUCAM), Digestive-Disease-Week Japan 2004 scale (DDW-J), and Clinical Diagnostic Scale (CDS). The purpose of this review is to assess these tools and discuss how to improve the causality assessment process as a whole. Recent findings Existing DILI-specific causality assessment tools are surprisingly similar and exhibit only minor differences in point allocation. But difference in threshold for likelihood of being DILI. We reviewed the literature on currently used causality assessment tools, identified areas for future improvement, and herein propose approaches for refinement. Opportunities to improve current models, as well as the assessment process, in general, include in particular provision of more precise clinical detail and to perhaps add new components to scoring systems. For example, the incorporation of drug-specific clinical signature patterns, accounting for a drug's inherent hepatotoxicity potential, and/or incorporation of other drug properties to scoring systems may allow enhancement. Further, more systemic exclusion of competing diagnoses is needed. Finally, causality assessment processes will likely benefit from a data-driven and computer-assisted approach. Summary Current tools used for DILI adjudication are imperfect. Avenues to improve these tools ar...
Source: Current Opinion in Gastroenterology - Category: Gastroenterology Tags: LIVER: Edited by Don C. Rockey Source Type: research

Related Links:

Lab Chip, 2019, Accepted Manuscript DOI: 10.1039/C9LC00354A, PaperBeyza Bulutoglu, Camilo Rey Bedon, Young-Bok (Abraham) Kang, Safak MERT, Martin L. Yarmush, Berk Usta Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) affect 25% of the world population. NAFLD is predicted to soon become the main cause of liver morbidity... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Lab Chip latest articles - Category: Chemistry Authors: Source Type: research
Authors: Liu Q, Liu S, Chen L, Zhao Z, Du S, Dong Q, Xin Y, Xuan S Abstract Non-alcoholic fatty liver disease (NAFLD), the most prevalent chronic liver disease in the world, is affected by numerous extrinsic and intrinsic factors, including lifestyle, environment, diet, genetic susceptibility, metabolic syndrome and gut microbiota. Accumulating evidence has proven that gut dysbiosis is significantly associated with the development and progression of NAFLD, and several highly variable species in gut microbiota have been identified. The gut microbiota contributes to NAFLD by abnormal regulation of the liver-gut axis,...
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
Condition:   Non-Alcoholic Fatty Liver Disease Intervention:   Sponsor:   Imperial College London Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Nonalcoholic Fatty Liver Disease (NAFLD) Intervention:   Procedure: Bariatric surgery Sponsor:   Taipei Medical University Hospital Enrolling by invitation
Source: - Category: Research Source Type: clinical trials
To the Editor: We would like to congratulate Sanford et  al on their comparison of proton versus photon treatment in 133 patients with hepatocellular carcinoma (HCC).1 Nonrandomized comparisons of patients with HCC are challenging because survival rates are affected by etiology of liver disease and baseline liver function. We note that 59% of proton pat ients had well-compensated liver function (Child-Pugh A5) versus 36% of photon patients. After accounting for imbalances in a multivariable analysis, differences in clinically relevant endpoints (nonclassic radiation-induced liver toxicity and overall survival) persist...
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Comment Source Type: research
BC Transplant says a misunderstanding about the guidelines concerning alcohol abstinence and liver transplants triggered a human rights complaint filed earlier this week by a B.C. man who has end-stage liver disease.
Source: CBC | Health - Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news
Publication date: Available online 14 August 2019Source: Pesticide Biochemistry and PhysiologyAuthor(s): Farzin Firouzian, Parisa Pourshoja, Amir Nili-Ahmadabadi, Akram RanjbarAbstractParaquat (PQ) is widely used as a herbicide around the world. PQ intoxication causes liver disease mainly in mammals. N-acetyl cysteine (NAC) is a medication that has positive effects in reducing the liver intoxication caused by PQ. Here, after formulating a NAC noisome nanoparticle (NACNP), we compared the niosomes and NAC on liver toxicity caused by PQ. Thirty male rats were divided into 5 groups and were treated intraperitoneally with PQ a...
Source: Pesticide Biochemistry and Physiology - Category: Biochemistry Source Type: research
Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Indication for adjuvant chemotherapy in ypN0 rectal cancer patients after chemoradiotherapy (CRT) is debated. The clinical significance of the presence of sterilized lymph nodes (LNS) in ypN0 patients remains to be determined.
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Tags: Oncology Source Type: research
Perioperative chemotherapy is the gold standard in gastric cancer management. The prognostic significance of pathological response has been investigated in many malignancies, using Tumor Regression Grade (TRG). Its prognostic value in gastric cancer remains poorly known.
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Tags: Original article Source Type: research
More News: Computers | Gastroenterology | Japan Health | Liver | Liver Disease | Urology & Nephrology